These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35066317)

  • 1. 6-Benzyloxyphthalides as selective and reversible monoamine oxidase B inhibitors with antioxidant and anti-neuroinflammatory activities for Parkinson's disease treatment.
    Song Q; Yu G; Li W; Xu Y; Cong S; Liu X; Tan Z; Deng Y
    Bioorg Chem; 2022 Mar; 120():105623. PubMed ID: 35066317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Hydroxy-4-benzyloxylimine Resveratrol Derivatives as Potential Multifunctional Agents for the Treatment of Parkinson's Disease.
    Cao Z; Zhang T; Fu X; Wang X; Xia Q; Zhong L; Zhu J
    ChemMedChem; 2023 Mar; 18(6):e202200629. PubMed ID: 36622947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel 2-hydroxyl-4-benzyloxybenzyl aniline derivatives as potential multifunctional agents for the treatment of Parkinson's disease.
    Cao Z; Fu X; Wang X; Zhang T; Zhong L; Xia Q; Zhu J
    Eur J Med Chem; 2023 Mar; 249():115142. PubMed ID: 36716641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies.
    Elkamhawy A; Paik S; Park JH; Kim HJ; Hassan AHE; Lee K; Park KD; Roh EJ
    Bioorg Chem; 2021 Oct; 115():105233. PubMed ID: 34390968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel 2-(4-(benzyloxy)-5-(hydroxyl) phenyl) benzothiazole derivatives as multifunctional MAO-B inhibitors for the treatment of Parkinson's disease.
    Cao Z; Wang X; Zhang T; Fu X; Zhang F; Zhu J
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2159957. PubMed ID: 36728713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of biaryl derivatives for structural characterization of selective monoamine oxidase B inhibitors toward Parkinson's disease therapy.
    Yeon SK; Choi JW; Park JH; Lee YR; Kim HJ; Shin SJ; Jang BK; Kim S; Bahn YS; Han G; Lee YS; Pae AN; Park KD
    Bioorg Med Chem; 2018 Jan; 26(1):232-244. PubMed ID: 29198609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and evaluation of novel monoamine oxidase B (MAO-B) inhibitors with improved pharmacokinetic properties for Parkinson's disease.
    Yi C; Liu X; Chen K; Liang H; Jin C
    Eur J Med Chem; 2023 Apr; 252():115308. PubMed ID: 37001389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzyloxynitrostyrene analogues - A novel class of selective and highly potent inhibitors of monoamine oxidase B.
    Van der Walt MM; Terre'Blanche G; Petzer JP; Petzer A
    Eur J Med Chem; 2017 Jan; 125():1193-1199. PubMed ID: 27855360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-[2-(4-Benzyloxyphenoxy)Ethyl]Imidazole inhibits monoamine oxidase B and protects against neuronal loss and behavioral impairment in rodent models of Parkinson's disease.
    Chung JY; Lee JW; Ryu CH; Min HK; Yoon YJ; Lim MJ; Park CH
    J Neurosci Res; 2015 Aug; 93(8):1267-78. PubMed ID: 25711470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel benzimidazole derivatives as selective and reversible monoamine oxidase B inhibitors for Parkinson's disease treatment.
    Lv Y; Fan M; He J; Song X; Guo J; Gao B; Zhang J; Zhang C; Xie Y
    Eur J Med Chem; 2024 Aug; 274():116566. PubMed ID: 38838545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing monoamine oxidase B inhibitory activity via chiral fluorination: Structure-activity relationship, biological evaluation, and molecular docking study.
    Wang Z; Yi C; Chen K; Wang T; Deng K; Jin C; Hao G
    Eur J Med Chem; 2022 Jan; 228():114025. PubMed ID: 34871839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyridoxine-resveratrol hybrids as novel inhibitors of MAO-B with antioxidant and neuroprotective activities for the treatment of Parkinson's disease.
    Li W; Yang X; Song Q; Cao Z; Shi Y; Deng Y; Zhang L
    Bioorg Chem; 2020 Apr; 97():103707. PubMed ID: 32146176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of coumarin Mannich base derivatives as multifunctional agents against monoamine oxidase B and neuroinflammation for the treatment of Parkinson's disease.
    Tao D; Wang Y; Bao XQ; Yang BB; Gao F; Wang L; Zhang D; Li L
    Eur J Med Chem; 2019 Jul; 173():203-212. PubMed ID: 31005056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of novel 3,4-dihydrocoumarins as potent and selective monoamine oxidase-B inhibitors with the neuroprotection against Parkinson's disease.
    Liu L; Chen Y; Zeng RF; Liu Y; Xie SS; Lan JS; Ding Y; Yang YT; Yang J; Zhang T
    Bioorg Chem; 2021 Apr; 109():104685. PubMed ID: 33640631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents.
    Carradori S; Ortuso F; Petzer A; Bagetta D; De Monte C; Secci D; De Vita D; Guglielmi P; Zengin G; Aktumsek A; Alcaro S; Petzer JP
    Eur J Med Chem; 2018 Jan; 143():1543-1552. PubMed ID: 29126727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors.
    Tzvetkov NT; Stammler HG; Neumann B; Hristova S; Antonov L; Gastreich M
    Eur J Med Chem; 2017 Feb; 127():470-492. PubMed ID: 28107736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition.
    Zheng H; Gal S; Weiner LM; Bar-Am O; Warshawsky A; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):68-78. PubMed ID: 16181413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, monoamine oxidase inhibitory activity and computational study of novel isoxazole derivatives as potential antiparkinson agents.
    Agrawal N; Mishra P
    Comput Biol Chem; 2019 Apr; 79():63-72. PubMed ID: 30731360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of 2-substituted 4(3H)-quinazolinone thioether derivatives as monoamine oxidase inhibitors.
    Qhobosheane MA; Petzer A; Petzer JP; Legoabe LJ
    Bioorg Med Chem; 2018 Nov; 26(20):5531-5537. PubMed ID: 30279044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of monoamine oxidase by indole and benzofuran derivatives.
    Prins LH; Petzer JP; Malan SF
    Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.